MoonLake Immunotherapeutics
As of the edition of 20 October 2026, MoonLake Immunotherapeutics runs 1 drug.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 1 |
| Total | 1 |
Where its trials are
- Skin and connective tissue: 9 trials led
- Infections: 5 trials led
- Bones, joints and muscles: 4 trials led